G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2011
05/19/2011	US20110117120 Plasmodium falciparum HLA class I restricted T-cell epitopes
05/19/2011	US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/19/2011	US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
05/19/2011	US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
05/19/2011	US20110117112 Sodium channel protein type iii alpha-subunit splice variant
05/19/2011	US20110117111 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
05/19/2011	US20110117107 Compositions and methods for diagnosis, prognosis and management of malaria
05/19/2011	US20110117105 Method of treating immune disease using b-cell antibodies
05/19/2011	US20110117103 Anti-sweat antigen monoclonal antibody
05/19/2011	US20110117100 Compositions and methods for diagnosis, stratification and treatment of amyloidogenic diseases
05/19/2011	US20110117096 Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies
05/19/2011	US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011	US20110117090 Adam-15 antibodies and immunogenic peptides
05/19/2011	US20110117086 Monoclonal antibodies to progastrin and their uses
05/19/2011	US20110117083 Biological markers for monitoring patient response to vegf antagonists
05/19/2011	US20110117080 Anti-REG4 Antibodies
05/19/2011	US20110117066 Established human brown adipocyte line and method for differentiation from an hmads cell line
05/19/2011	US20110117023 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same
05/19/2011	US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof
05/19/2011	US20110117013 Compositions against cancer antigen liv-1 and uses thereof
05/19/2011	US20110116972 Microfluidic assays and microfluidic devices
05/19/2011	US20110116971 Agitating device
05/19/2011	US20110114719 System and Method for the Unequivocal Allocation of Histological Cassettes and Specimen Slides
05/19/2011	US20110113865 Using cardiac troponin for monitoring anti-angiogenesis therapy
05/19/2011	US20110113864 Identification of subjects being susceptible to anti-angiogenesis therapy
05/19/2011	US20110113863 Means and methods diagnosing gastric bypass and conditions related thereto
05/19/2011	US20110113859 Low-voltage thin-film field-effect transistors
05/19/2011	US20110113858 Gas charge container, atom probe apparatus, and method for analyzing hydrogen position in material
05/19/2011	DE202009018243U1 Vorrichtung zur agglutinationsbasierten Erkennung von spezifischen Erkrankungen über einen Bluttest Device for detection of specific diseases agglutinationsbasierten a blood test
05/19/2011	DE112009001703T5 Mittel und Verfahren zur Diagnostik von Magenbypass und damit verbundenen Zuständen Means and methods for the diagnosis of gastric bypass and conditions associated therewith
05/19/2011	DE112008000888T5 Nichtspezifische verzögerte Überempfindlichkeitsreaktion zur Behandlung von Herpes-Simplex-Virusinfektionen Non-specific delayed hypersensitivity response for the treatment of herpes simplex virus infections
05/19/2011	DE10296990B4 Verwendung eines Biochips zur Diagnose von Sepsis und sepsisähnlichem Syndrom Using a biochip for the diagnosis of sepsis and sepsis-like syndrome
05/19/2011	DE102009054097A1 Verfahren zum Bestimmen der Feuchtigkeit bei einem absorbierenden Hygienartikel und Vorrichtung zur Durchführung des Verfahrens A method for determining the moisture in an absorbent hygiene articles, and apparatus for carrying out the method
05/19/2011	DE102009052673A1 Vorrichtung zur Bestimmung der Impedanz von Zellschichten Apparatus for determining the impedance of the cell layers
05/19/2011	CA2786118A1 Methods for pcr and hla typing using raw blood
05/19/2011	CA2780871A1 Self-flowing measuring system
05/19/2011	CA2780753A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
05/19/2011	CA2780740A1 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
05/19/2011	CA2780541A1 Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
05/19/2011	CA2780430A1 Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
05/19/2011	CA2780320A1 Rational design of regenerative medicine products
05/19/2011	CA2780301A1 Risk factors and prediction of myocardial infarction
05/19/2011	CA2780208A1 Therapeutic and diagnostic applications against trypanosomosis
05/19/2011	CA2780044A1 Biomarkers for predicting rapid response to hcv treatment
05/19/2011	CA2780024A1 Immunoassay for assessing related analytes of different origin
05/19/2011	CA2779950A1 Method of inspection of sealed capsules with a process of determination of the quality of the seal and related equipment for in-line inspection
05/19/2011	CA2779843A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
05/19/2011	CA2779683A1 Anti-c-mpl antibodies
05/19/2011	CA2779606A1 Heart aging biomarkers and methods of use
05/19/2011	CA2779293A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011	CA2779076A1 Anti-trypanosomiasis vaccines and diagnostics
05/19/2011	CA2778953A1 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
05/19/2011	CA2778866A1 Calibration reagent and uses thereof
05/19/2011	CA2777909A1 Metal sputtered monofilament or multifilament hppe yarns
05/19/2011	CA2777549A1 Copy number analysis of genetic locus
05/19/2011	CA2776332A1 Underfill recognition system for a biosensor
05/18/2011	EP2322936A1 Methods for identifying a lead compound for treatment of Alzheimer's disease
05/18/2011	EP2322935A1 Method for evaluating myocardial ischemic state using blood sample
05/18/2011	EP2322934A1 A Kit for diagnosing the Alzheimer's disease
05/18/2011	EP2322933A1 Diagnosis of carcinomas
05/18/2011	EP2322932A2 Detection of tuberculosis and infection by mycobacterium tuberculosis using HBHA
05/18/2011	EP2322931A2 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
05/18/2011	EP2322930A2 Sequences for detection and identification of methicillin-resistant Staphylococcus Aureus (MRSA) of MREJ type xiv
05/18/2011	EP2322929A1 Diagnostics, drug screening and treatment for cancer
05/18/2011	EP2322928A1 Method for monitoring the immune response and predicting clinical outcomes in transplant recipients using ATP measurement in lymphocytes
05/18/2011	EP2322927A1 Compounds inhibiting CD95 signaling for the treatment of pancreatic cancer
05/18/2011	EP2322926A1 Stabilized open form transglutaminase as a diagnostic indicator for autoimmune diseases
05/18/2011	EP2322925A2 Device for determining the impedance of cell layers
05/18/2011	EP2322924A1 Protection from hydrophobic agents
05/18/2011	EP2322923A2 Method for procyanidin analysis
05/18/2011	EP2322921A1 DNTP conjugated to peptide via a UV cleavable linker
05/18/2011	EP2322920A1 MALDI tissue imaging using conjugates cleavable by fast fragmentation
05/18/2011	EP2322914A1 Analyte concentration detection devices and methods
05/18/2011	EP2322910A2 A method of analysing a sample of free cells
05/18/2011	EP2322671A1 Prediction system for the graphitization index in specific areas of vermicular graphitic cast iron pieces
05/18/2011	EP2322659A1 Method and specimen for detecting sensitivity to isoniazid in tubercle bacillus
05/18/2011	EP2322649A1 Method for rapid detection and identification of bioagents
05/18/2011	EP2322646A1 Method of detecting platelet thrombosis or organ failure
05/18/2011	EP2322645A1 Mass transport limited in vivo analyte sensor
05/18/2011	EP2322628A2 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322627A2 Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322625A1 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
05/18/2011	EP2322624A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322623A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322622A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322621A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322610A1 Anti-human clcp1 antibody and use thereof
05/18/2011	EP2322605A2 Terpene synthases
05/18/2011	EP2322562A1 Monoclonal antibody, and immunoassay using same
05/18/2011	EP2322559A2 Neoplasm specific antibodies and uses thereof
05/18/2011	EP2322553A2 Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
05/18/2011	EP2322548A1 NPC1L1 (NPC) and methods of use thereof
05/18/2011	EP2322539A2 A method for identification, isolation and production of antigens to a specific pathogen
05/18/2011	EP2322538A1 Compounds for the diagnosis of diseases associated with VCAM expression
05/18/2011	EP2322531A2 Methods for the diagnosis of dementia and other neurological disorders
05/18/2011	EP2322524A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/18/2011	EP2322224A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322213A1 Cancerous disease modifying antibodies
05/18/2011	EP2322209A2 Tumor specific oligosaccharide epitopes and use thereof

1 ... 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 ... 3937